Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PixCell Medical Technologies Ltd. Announces $2 Million Raise Following Successful Completion of CE Mark Registration of the HemoScreen CBC Analyzer
  • USA - English


News provided by

PixCell Medical Technologies Ltd.

Oct 04, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

HemoScreen CBC Analyzer for the POC
HemoScreen CBC Analyzer for the POC

Yokneam Ilit, Israel, October 1st,2013 (PRWEB) October 04, 2013 -- PixCell Medical Technologies Ltd. a privately held company focused on developing its patented Cell Based Diagnostics technology for the Point of Care (POC), announced that it has raised $2 million following successful completion of CE mark registration of the HemoScreen Complete Blood Count (CBC) analyzer from its existing strategic investor.

PixCell’s goal is to make lab restricted tests more accessible, easy to use and affordable.

Post this

This recent investment round will be used to establish PixCell’s European presence and expand its ongoing clinical efforts to introduce the HemoScreen technology to the market. HemoScreen CBC analyzer brings the laboratory to physicians' offices, to patient’s homes, isolated communities, ambulances and even to field units. Requiring only a minute blood sample and zero maintenance, it is also ideal for newborns hematology assessment.

PixCell's Viscoelastic Focusing and automated sample preparation proprietary technology, presents a breakthrough in live cell diagnostics, utilizing lab accurate and robust testers yet small sized, simple to operate and inexpensive.

“We are thrilled with our investors’ commitment to make HemoScreen POC technology available and accessible”, said PixCell Medical CEO Dr. Avishay Bransky. “PixCell’s goal is to make lab restricted tests more accessible, easy to use and affordable. With this new investment, PixCell is poised to expand its clinical efforts and further demonstrate how the HemoScreen technology can support diagnostics and treatment selection at the point of care.”

PixCell’s HemoScreen is a miniature, portable Point of Care Complete Blood Count (CBC) tester that employs disposable self-contained cartridges. The HemoScreen provides 20 standard CBC parameters including: RBC indices, WBC count, Hemoglobin, WBC 5-diff and platelets parameters. Tests results are obtained within 5 minutes using only 20µl of capillary/venous blood.

PixCell Medical plans to start a multi-center pilot study in Europe and Israel to evaluate the safety and performance of the HemoScreen system. Prior pre-clinical studies have successfully demonstrated its precision and accuracy in CBC analysis.

The company will be participating at the upcoming Medica trade fair with a hands-on HemoScreen Technology demonstration in Hall 16 Stand G40. Medica will be held November 20-23, 2013 in Dusseldorf, Germany.

About PixCell Medical Technologies Ltd.
PixCell Medical Technologies is an innovative privately held company developing Cell-Based Diagnostics for the Point of Care (POC), based on its patented viscoelastic focusing and microfluidics technology. The core technology is comprised of an Analyzer and a Self-Contained Disposable Cartridge.
• Viscoelastic Focusing – a new physical phenomenon that was recently discovered at the Technion – Israel Institute of Technology and is exclusively licensed to PixCell Medical. Viscoelastic Focusing causes cells, which are suspended in the patented fluid, to perfectly align i.e. focus and facilitate their optical detection and analysis.
• Disposable Cartridge – PixCell’s patent pending self-contained single-use cartridge enables whole blood sample collection and automated sample preparation in a simple single step.
• Novel Microfluidic Chip – The pure plastic chip is based on a propriety design which facilitates simultaneous multiple analyses on the same sample.
• Image-Based Analysis – advanced machine-learning algorithms are employed in order to analyze the sample instantly.

For more information, please contact:
PixCell Medical Technologies Ltd.
6 Hayezira St., POB 113, Yokneam Ilit 20692, Israel
Tel: +972-4-959-3516 / 7, Fax: +972-4-959-3518
Mail: info(at)pixcell-medical(dot)com

Hanan Ben-Asher, PixCell Medical Technologies Ltd., http://www.pixcell-medical.com, +972 542355444, [email protected]

Modal title

Company Overview
View PDF
Company Overview
HemoScreen CBC Analyzer Overview
View PDF
HemoScreen CBC Analyzer Overview
Company Overview HemoScreen CBC Analyzer Overview

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.